JP2026505092A5 - - Google Patents

Info

Publication number
JP2026505092A5
JP2026505092A5 JP2025544851A JP2025544851A JP2026505092A5 JP 2026505092 A5 JP2026505092 A5 JP 2026505092A5 JP 2025544851 A JP2025544851 A JP 2025544851A JP 2025544851 A JP2025544851 A JP 2025544851A JP 2026505092 A5 JP2026505092 A5 JP 2026505092A5
Authority
JP
Japan
Prior art keywords
injectable composition
composition according
albumin
producing
dimethylimidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025544851A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026505092A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2024/050869 external-priority patent/WO2024161316A1/en
Publication of JP2026505092A publication Critical patent/JP2026505092A/ja
Publication of JP2026505092A5 publication Critical patent/JP2026505092A5/ja
Pending legal-status Critical Current

Links

JP2025544851A 2023-02-01 2024-01-31 注射用組成物、それを含む医薬製剤及びその製造方法 Pending JP2026505092A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2023-0013947 2023-02-01
KR20230013947 2023-02-01
PCT/IB2024/050869 WO2024161316A1 (en) 2023-02-01 2024-01-31 Injectable composition, pharmaceutical formulation including the same, and method for preparing the composition

Publications (2)

Publication Number Publication Date
JP2026505092A JP2026505092A (ja) 2026-02-10
JP2026505092A5 true JP2026505092A5 (https=) 2026-04-30

Family

ID=92024104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025544851A Pending JP2026505092A (ja) 2023-02-01 2024-01-31 注射用組成物、それを含む医薬製剤及びその製造方法

Country Status (15)

Country Link
EP (1) EP4658244A1 (https=)
JP (1) JP2026505092A (https=)
KR (1) KR20240121186A (https=)
CN (1) CN118415999A (https=)
AR (1) AR131668A1 (https=)
AU (1) AU2024215883A1 (https=)
CL (1) CL2025002270A1 (https=)
CO (1) CO2025011347A2 (https=)
DO (1) DOP2025000185A (https=)
IL (1) IL322431A (https=)
JO (1) JOP20250189A1 (https=)
MX (1) MX2025008735A (https=)
PE (1) PE20252396A1 (https=)
TW (1) TW202432120A (https=)
WO (1) WO2024161316A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120827558A (zh) * 2024-04-19 2025-10-24 丽珠医药集团股份有限公司 咪唑并[1,2-a]吡啶衍生物药物组合物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1682133A1 (en) * 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
AR051041A1 (es) * 2004-10-04 2006-12-13 Altana Pharma Ag Bencimidazoles triciclicos condensados
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
GB0906470D0 (en) * 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도

Similar Documents

Publication Publication Date Title
US10548844B2 (en) pH-responsive mucoadhesive polymeric encapsulated microorganisms
AU2008337269B2 (en) Formulations comprising exine shells
JP3303884B2 (ja) 新規凍結乾燥組成物ならびに薬剤、生物製剤、栄養分および食品の経口投与方法
JP2975112B2 (ja) 控えめな水溶性をもつ医薬物質の固体及び液体溶液
JP2015519330A5 (https=)
TWI428140B (zh) A freeze-dried preparation containing influenza vaccine and a method for producing the same
JP2026505092A5 (https=)
Madani et al. An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery
MX2013002802A (es) Composicion farmaceutica.
Markwalter et al. Sustained release of peptides and proteins from polymeric nanocarriers produced by inverse Flash NanoPrecipitation
Jadhav et al. Mesoporous silica nanoparticles (MSN): a nanonetwork and hierarchical structure in drug delivery
JP2006500367A (ja) ブチルフタリドとシクロデキストリンまたはその誘導体との包接複合体、それらの調製のためのプロセスおよびその使用
CN104739806A (zh) 口服胰岛素复合微囊及制备方法
WO2014121611A1 (zh) 一种稳定的诺卡沙星粉针冻干剂
TW202432120A (zh) 注射用組合物、包含其之醫藥調配物以及製備該組合物之方法
CN110251484B (zh) 一种纳米胶囊型聚多巴胺药物材料及其制备方法与应用
JP2020507586A (ja) ゾル−ゲル/ヒドロゲル治療薬送達システム及びその方法
JP2016507535A5 (https=)
CN106963941A (zh) 一种具有肠道粘液穿透能力的胰岛素口服剂及其制备方法
JP2019535801A5 (https=)
ES2809254T3 (es) Microcápsulas de piperaquina y composiciones que las contienen
JPS59175414A (ja) マクロライド抗生物質の安定な経口用製剤および安定化法
JP2009544684A (ja) デンプンを含むコーティング組成物
CN110393711A (zh) 一种改善plga载多肽类药物微球中药物低包封和高初始突释问题的方法
JP2004523570A (ja) 味をマスキングしたテリスロマイシンの懸濁物